Long term results of HDR brachytherapy in men older than 75 with localized carcinoma of the prostate

Reports of Practical Oncology and Radiotherapy

Volumn 18, Issue 1, 2013, Pages 11-15

  Soumarová, Renata ^a,b   Homola, Luboš ^a   Perková, Hana ^a  

^a Department of Radiotherapy and Oncology   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

Author keywords

High dose rate (HDR) brachytherapy; Localized prostate cancer; Older man

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG TERM CARE; MALE; MORTALITY; PROSTATE CARCINOMA; TUMOR LOCALIZATION; URINARY TRACT DISEASE;

EID: 84875246435     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2012.08.005     Document Type: Article

References (20)

1. Cardia J., Calçada C., Pereira H. Treatment of lung cancer in the elderly: influence of comorbidity on toxicity and survival. Rep Pract Oncol Radiother 2011, 16(2):45-48.
2. Alibhai S.M., Leach M., Warde P. Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery. Cancer 2009, 115(2):293-302.
3. Trinh QD, Schmitges J, Sun M, et al. Open radical prostatectomy in the elderly: a case for concern? BJU Int, in press.
4. Borrusch H., Müller G., Otto U. Urinary incontinence after radical prostatectomy: do older patients have an increased risk?. Urologe A 2011, 50(4):457-461.
5. Shikanov S., Desai V., Razmaria A., Zagaja G.P., Shalhav A.L. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery. J Urol 2010, 183(5):1803-1807.
6. Xylinas E., Ploussard G., Paul A., et al. Laparoscopic radical prostatectomy in the elderly (>75 years old): oncological and functional results. Prog Urol 2010, 20(2):116-120.
7. Tarragón Gabarró S., Lorente Garín J.A., del Canto Aguirre M., et al. Perioperative morbidity of radical prostatectomy in patients over 70 years of age. Actas Urol Esp 2009, 33(9):960-964.
8. Froehner M, Hentschel C, Koch R, Litz RJ, Hakenberg OW, Wirth MP. Which comorbidity classification best fits elderly candidates for radical prostatectomy? Urol Oncol, in press.
9. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53(5):1097-1105.
10. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998, 41(3):491-500.
11. Valicenti R., Lu J., Pilepich M., et al. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 2000, 18(14):2740-2746.
12. Kupelian P., Kuban D., Thames H., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 2005, 61(2):415-419.
13. Droz J.P., Balducci L., Bolla M., et al. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 2010, 106(4):462-469.
14. Roberts C.B., Albertsen P.C., Shao Y.H., et al. Patterns and correlates of prostate cancer treatment in older men. Am J Med 2011, 124(3):235-243.
15. Konety B.R., Cowan J.E., Carroll P.R., CaPSURE Investigators Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol 2008, 179(5):1797-1803. discussion 1803.
16. Hayes J.H., Ollendorf D.A., Pearson S.D., et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA 2010, 304(21):2373-2380.
17. Saigal C.S., Gore J.L., Krupski T.L., et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 2007, 110(7):1493-1500.
18. Hamstra DA, Bae K, Pilepich MV, et al. Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of Radiation Therapy Oncology Group Trials. Int J Radiat Oncol Biol Phys, in press.
19. Alibhai S.M., Naglie G., Nam R., Trachtenberg J., Krahn M.D. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol 2003, 21(17):3318-3327.
20. Chen A.B., D'Amico A.V., Neville B.A., Earle C.C. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 2006, 24(33):5298-5304.